Varifarma

Passionate about
quality, research, and
innovation

Our expertise,
your quality
of life

Remarkable
and unceasing
expansion

Elevating healthcare
through international
partnerships

Through our relentless dedication, we have emerged as frontrunners in the fields of oncology, hematology, transplant cases, and rare diseases. Since 2004, we have proudly partnered with over 15 international companies and extended our reach to several other Latin American nations.

Our Commitment to
Excellence

Our primary focus is on developing and manufacturing high-quality pharmaceuticals, driven by an unwavering commitment to optimizing patient care. Our distinguished reputation stems from long-standing collaborations with the medical and scientific communities, where we prioritize innovation and continuous improvement in line with rigorous international quality standards.

Global and Latin American Products

+

380

registered
products worldwide

+

350

products in
Latin America

Search Products

1
Oncology

Oncology
Hematology

Hematology
Onco-Hematology

Onco-Hematology
Genomic Test

Genomic Test
Transplant

Transplant
Rare Diseases

Rare Diseases
Hospital Portfolio

Hospital Portfolio

News

ARG
04.2025

SAU International Symposium “Advances in Urology 2025”

Varifarma Symposium: "Clinical Experience with GORAX (Relugolix 120 mg) in Advanced Prostate Cancer" at SAU Conference from April 10 to 11.

UY
03.2025

Varifarma at the Third Integrated Conference of the Academic Hematology Unit

Present at the “Daily Hematology” Conference in Montevideo from March 12 to 14.

ARG
02.2025

Posaconazol Varifarma® - New Hospital Product

Confidence in the control of complex fungal infections.

UY
11.2024

Varifarma contributing the latest updates on genomic tests.

Discover our participation in the event we joined alongside the Uruguayan Society of Medical and Pediatric Oncology.

ARG
11.2024

¡New Launching! Canitib® (Neratinib)

We are expanding our portfolio with another product for breast cancer treatment.

CH
11.2024

Launch of Medikinet® (Methylphenidate Hydrochloride)

New treatment for ADHD.

UY CL PE EC ARG
10.2024

At the forefront of oncohematology: Varifarma at the New York Congress

 24th Lymphoma, Leukemia, and Myeloma Congress: the ideal scenario to reaffirm our commitment.

UY EC PE CL ARG
10.2024

Varifarma at CPHI 2024: Leading innovation.

 Leading the pharmaceutical industry into the future.

UY
10.2024

Varifarma: shaping the future of Hematology in Uruguay

We had the pleasure of attending the Hematology Update Conference on October 1st.

EC CL PE UY ARG
10.2024

ESMO 2024: Oncology advances with Varifarma!

A record-breaking congress with the latest innovations.  

ARG
09.2024

BOCIPAL® (Relugolix 40mg) HAS BEEN LAUNCHED!

A different approach to managing symptoms associated with uterine fibroids.

ARG
09.2024

Gorax Symposium: A Full House! Discover the Highlights

Connecting with the medical community at the 61st Argentine Congress of Urology, hosted by the SAU.

ARG
11.2024

Gorax® Symposium a Great Success at UROTARGET 2024

Setting a new standard of care in advanced prostate cancer treatment.

Vadrox Hipular Linotax Bocipal Gorax Bozatinix Binap Nibclus Nadrib Anfonax Ixafnib Lenvatib